In this article, several hypotheses for this impaired efficacy have been explored, including the impaired regulation of aromatase in obesity as well as the role of PI3K, leptin, and FGFR1 signalling. The gene discussed is CYP19A1; the disease is obesity due to melanocortin 4 receptor deficiency.